Mauro D'Amato

Professor Mauro D'Amato

Research Overview

Our team combines genomic, computational and pre-clinical expertise to elucidate the pathogenetic mechanisms predisposing to gastrointestinal (GI) disease. The druggable genome, nutrigenetics and host (genome) - microbiota interactions are also new research lines within the group. We take advantage of an extremely vast network of international collaboration with academic, clinical and pharma partners worlwide; the ultimate goal of our studies is their translational application for therapeutic precision in gastroenterology.